TCERG1
Transcription elongation regulator 1
Also known as: CA150, TAF2S, TCRG1_HUMAN, Urn1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O14776
- Gene
- TCERG1
- Ensembl
- ENSG00000113649
- Chromosome
- 5
- Canonical length
- 1098 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a nuclear protein that regulates transcriptional elongation and pre-mRNA splicing. The encoded protein interacts with the hyperphosphorylated C-terminal domain of RNA polymerase II via multiple FF domains, and with the pre-mRNA splicing factor SF1 via a WW domain. Alternative splicing results in multiple transcripts variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1098 residues, UniProt reviewed canonical sequence.
>O14776|TCERG1
1 MAERGGDGGE SERFNPGELR MAQQQALRFR GPAPPPNAVM RGPPPLMRPP PPFGMMRGPP
61 PPPRPPFGRP PFDPNMPPMP PPGGIPPPMG PPHLQRPPFM PPPMSSMPPP PGMMFPPGMP
121 PVTAPGTPAL PPTEEIWVEN KTPDGKVYYY NARTRESAWT KPDGVKVIQQ SELTPMLAAQ
181 AQVQAQAQAQ AQAQAQAQAQ AQAQAQAQAQ AQAQAQAQAQ AQAQAQAQAQ AQAQAQAQAQ
241 AQVQAQVQAQ VQAQAVGAST PTTSSPAPAV STSTSSSTPS STTSTTTTAT SVAQTVSTPT
301 TQDQTPSSAV SVATPTVSVS TPAPTATPVQ TVPQPHPQTL PPAVPHSVPQ PTTAIPAFPP
361 VMVPPFRVPL PGMPIPLPGV AMMQIVSCPY VKTVATTKTG VLPGMAPPIV PMIHPQVAIA
421 ASPATLAGAT AVSEWTEYKT ADGKTYYYNN RTLESTWEKP QELKEKEKLE EKIKEPIKEP
481 SEEPLPMETE EEDPKEEPIK EIKEEPKEEE MTEEEKAAQK AKPVATAPIP GTPWCVVWTG
541 DERVFFYNPT TRLSMWDRPD DLIGRADVDK IIQEPPHKKG MEELKKLRHP TPTMLSIQKW
601 QFSMSAIKEE QELMEEINED EPVKAKKRKR DDNKDIDSEK EAAMEAEIKA ARERAIVPLE
661 ARMKQFKDML LERGVSAFST WEKELHKIVF DPRYLLLNPK ERKQVFDQYV KTRAEEERRE
721 KKNKIMQAKE DFKKMMEEAK FNPRATFSEF AAKHAKDSRF KAIEKMKDRE ALFNEFVAAA
781 RKKEKEDSKT RGEKIKSDFF ELLSNHHLDS QSRWSKVKDK VESDPRYKAV DSSSMREDLF
841 KQYIEKIAKN LDSEKEKELE RQARIEASLR EREREVQKAR SEQTKEIDRE REQHKREEAI
901 QNFKALLSDM VRSSDVSWSD TRRTLRKDHR WESGSLLERE EKEKLFNEHI EALTKKKREH
961 FRQLLDETSA ITLTSTWKEV KKIIKEDPRC IKFSSSDRKK QREFEEYIRD KYITAKADFR
1021 TLLKETKFIT YRSKKLIQES DQHLKDVEKI LQNDKRYLVL DCVPEERRKL IVAYVDDLDR
1081 RGPPPPPTAS EPTRRSTKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCERG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 27 nTPM
- cerebellum: 23 nTPM
- skeletal muscle: 23 nTPM
- thymus: 18 nTPM
- lymph node: 17 nTPM
- tonsil: 16 nTPM
Single-cell type
- erythrocyte progenitors: 227 nCPM
- megakaryocyte-erythroid progenitors: 177 nCPM
- sertoli cells: 173 nCPM
- monocyte progenitors: 172 nCPM
- gonadotrophs: 166 nCPM
- prostatic hillock cells: 152 nCPM
Immune cell
- non-classical monocyte: 12 nTPM
- myeloid DC: 9.7 nTPM
- NK-cell: 9.6 nTPM
- intermediate monocyte: 8.8 nTPM
- memory CD8 T-cell: 7.2 nTPM
- MAIT T-cell: 6.9 nTPM
Brain region
- cerebral cortex: 22 nTPM
- white matter: 19 nTPM
- cerebellum: 17 nTPM
- amygdala: 15 nTPM
- hippocampal formation: 15 nTPM
- thalamus: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TCERG1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 139 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.34
- DepMap mean gene effect
- -0.54
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- mRNA processing
- negative regulation of transcription by RNA polymerase II
- negative regulation of transcription elongation by RNA polymerase II
- positive regulation of transcription by RNA polymerase II
- positive regulation of transcription elongation by RNA polymerase II
- RNA splicing
Molecular functions
- identical protein binding
- RNA binding
- RNA polymerase binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription coactivator activity
- transcription coregulator activity
- transcription corepressor activity
- transcription elongation factor activity
- ubiquitin-like protein conjugating enzyme binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCERG1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCERG1 as an antibody target. Whether an autoantibody or antibody against TCERG1 could matter depends on whether native TCERG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCERG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCERG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...